NCT05869799View on ClinicalTrials.gov

Effect of Vigiis 101 Lactic Acid Bacteria Powder on Body Weight and Body Fat in Overweight Participants

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

March 31, 2025

Study Completion Date

April 30, 2025

Conditions
Body WeightBody FatOverweight
Interventions
DIETARY_SUPPLEMENT

Vigiis 101 Lactobacillus Capsules

Product ingredients: microcrystalline cellulose, corn starch, NTU 101 lactic acid bacteria powder (1.0 x 10\^10 CFU); capsule shell composition: HPMC (hydroxypropyl methylcellulose), purified water, titanium dioxide, gellan gum.

DIETARY_SUPPLEMENT

Placebo Capsules

Maltodextrin was used as a placebo

Trial Locations (1)

114202

RECRUITING

Tri-Service General Hospital, National Defense Medical Center, Taipei

All Listed Sponsors
lead

SunWay Biotech Co., LTD.

INDUSTRY